Skip to content

Randomized-controlled PMCF study of the efficacy of the use of MBST magnetic resonance therapy

Randomized-controlled PMCF study of the efficacy of the use of MBST magnetic resonance therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00030107
Enrollment
114
Registered
2022-09-30
Start date
2023-01-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M00-M99 S00-T98

Interventions

Group 1: Arm 1- Standard therapy + Intervention
Patients in this arm receive 9 units of MBST therapy during their 7-day inpatient stay (following endoprosthesis implantation). One unit of MBST therapy has a duration of 60 minutes. Group 2: Arm 2- S

Sponsors

MedTec Medizintechnik GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patient is at least 18 years old - Patient is scheduled for implantation of a total knee joint endoprosthesis - Patient is able to understand the nature, meaning and significance of his decision to participate in this study to recognize - Patient has given informed consent for study participation and data processing according to DSGVO signed - Compliance with the instructions for use of the MBST® ARTHRO-SPIN-FLEX

Exclusion criteria

Exclusion criteria: Implanted infusion, pain and insulin pumps; Cochlear implants and other implanted neurostimulators.

Design outcomes

Primary

MeasureTime frame
Change of Range of Motion (ROM) evaluate at visit 2, 3, 4, 5, 6 and 7; The investigator conduct this clinical examination.

Secondary

MeasureTime frame
- Questionnaire: Oxford Knee Score (OKS) at Visit 1, 2, 3, 4, 5, 6 and 7; - Questionnaire: Knee Injury Osteoarthritis Outcome Score (KOOS) at Visit 1, 2, 3, 4, 5, 6 and 7; - Questionnaire: Knee Society Score at Visit 1, 2, 3, 4, 5, 6 and 7; - Questionnaire: EQ-5D at Visit 1, 2, 3, 4, 5, 6 and 7; - Questionnaire: NRS Pain scale at Visit 1, 2, 3, 4, 5, 6 and 7; - Safety: Incidents, side effects

Countries

Germany

Contacts

Public ContactLars;Daniela Stephan;Penn

Sportorthopaedie Dresden;medXteam GmbH

dr.stephan@sportorthopaedie-dresden.de;daniela.penn@medxteam.de0351 88940313;+49 6321 9164000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026